Adam Colborn, JD, associate vice president of congressional affairs at AMCP, shares insights on the impact of the Most ...

What happens if the US ties drug prices to other nations? Discover how the most-favored-nation policy could shake the global ...

Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Our health care system needs to do a better job of diagnosing and supporting people with cannabis-related diseases,” a ...

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Biden-era ...

Missourians simply cannot afford their prescription drugs. More than one in four have skipped doses or split pills to make prescriptions last longer. Over half worry they won’t be able to afford their ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to the artificially low, government-set prices in other developed nations.

Total aggregate value of the drugs generating the highest sales in 2024 rose 6.5% vs. 2023, and jumped 53% over five years.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said Thursday. But the details, and their potential consequences, are still not ...

A recent White House executive order could make it harder for millions of Americans to access their life-saving medications.

Following a busy month for executive orders signed in May, June was relatively quiet with orders that didn’t gain much ...